{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:34Z","timestamp":1792782994069,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SingHealth Foundation Research Grant","award":["SHF\/FG426S\/2009"],"award-info":[{"award-number":["SHF\/FG426S\/2009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10549-018-4851-6","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T22:23:55Z","timestamp":1529533435000},"page":"719-735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype"],"prefix":"10.1007","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-5066","authenticated-orcid":false,"given":"Yoon-Sim","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakaran","family":"Munusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire H. T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Prawira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sau-Yeen","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swee-Ho","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong-Wee","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Sean","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B. H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B. H.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Callen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C. T.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aye-Aye","family":"Thike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay-Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S. G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"issue":"1","key":"4851_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","volume":"151","author":"SA Rasmussen","year":"2000","unstructured":"Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151(1):33\u201340","journal-title":"Am J Epidemiol"},{"issue":"1","key":"4851_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10689-006-9001-3","volume":"6","author":"S Griffiths","year":"2007","unstructured":"Griffiths S, Thompson P, Frayling I, Upadhyaya M (2007) Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer 6(1):21\u201334. \n                    https:\/\/doi.org\/10.1007\/s10689-006-9001-3","journal-title":"Fam Cancer"},{"issue":"15","key":"4851_CR3","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.18632\/oncotarget.2194","volume":"5","author":"YS Yap","year":"2014","unstructured":"Yap YS, McPherson JR, Ong CK, Rozen SG, Teh BT, Lee AS, Callen DF (2014) The NF1 gene revisited\u2014from bench to bedside. Oncotarget 5(15):5873\u20135892","journal-title":"Oncotarget"},{"issue":"17","key":"4851_CR4","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionpaa RA, Poyhonen M, Leppavirta J, Yla-Outinen H, Riccardi VM, Pukkala E, Pitkaniemi J, Peltonen S, Peltonen J (2016) Distinctive cancer associations in patients with neurofibromatosis Type 1. J Clin Oncol 34(17):1978\u20131986. \n                    https:\/\/doi.org\/10.1200\/jco.2015.65.3576","journal-title":"J Clin Oncol"},{"issue":"3","key":"4851_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu GF, O\u2019Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62(3):599\u2013608","journal-title":"Cell"},{"issue":"1","key":"4851_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","volume":"62","author":"RM Cawthon","year":"1990","unstructured":"Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O\u2019Connell P (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62(1):193\u2013201","journal-title":"Cell"},{"issue":"5","key":"4851_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","volume":"10","author":"H Brems","year":"2009","unstructured":"Brems H, Beert E, de Ravel T, Legius E (2009) Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10(5):508\u2013515. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(09)70033-6","journal-title":"Lancet Oncol"},{"issue":"8","key":"4851_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jmg.2007.049346","volume":"44","author":"S Sharif","year":"2007","unstructured":"Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DGR (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44(8):481\u2013484. \n                    https:\/\/doi.org\/10.1136\/jmg.2007.049346","journal-title":"J Med Genet"},{"issue":"12","key":"4851_CR9","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/ajmg.a.35560","volume":"158A","author":"X Wang","year":"2012","unstructured":"Wang X, Levin AM, Smolinski SE, Vigneau FD, Levin NK, Tainsky MA (2012) Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area. Am J Med Genet Part A 158A(12):3061\u20133064. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.35560","journal-title":"Am J Med Genet Part A"},{"issue":"12","key":"4851_CR10","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/ajmg.a.35550","volume":"158A","author":"SA Madanikia","year":"2012","unstructured":"Madanikia SA, Bergner A, Ye X, Blakeley JON (2012) Increased risk of breast cancer in women with NF1. Am J Med Genet A 158A(12):3056\u20133060. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.35550","journal-title":"Am J Med Genet A"},{"issue":"9","key":"4851_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/bjc.2015.78","volume":"112","author":"OO Seminog","year":"2015","unstructured":"Seminog OO, Goldacre MJ (2015) Age-specific risk of breast cancer in women with neurofibromatosis type 1. Br J Cancer 112(9):1546\u20131548. \n                    https:\/\/doi.org\/10.1038\/bjc.2015.78","journal-title":"Br J Cancer"},{"issue":"2","key":"4851_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/bjc.2016.403","volume":"116","author":"E Uusitalo","year":"2017","unstructured":"Uusitalo E, Kallionpaa RA, Kurki S, Rantanen M, Pitkaniemi J, Kronqvist P, Harkonen P, Huovinen R, Carpen O, Poyhonen M, Peltonen S, Peltonen J (2017) Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. Br J Cancer 116(2):211\u2013217. \n                    https:\/\/doi.org\/10.1038\/bjc.2016.403","journal-title":"Br J Cancer"},{"issue":"23","key":"4851_CR13","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243\u20132257. \n                    https:\/\/doi.org\/10.1056\/NEJMsr1501341","journal-title":"N Engl J Med"},{"key":"4851_CR14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.sabcs12-p3-08-09","author":"Y-S Yap","year":"2012","unstructured":"Yap Y-S, Wong J, Chan M, Yong W-S, Ong K-W, Lo S-K, Ngeow J, Tan B, Madhukumar P, Tan M-H, Ang P, Teh B-T, Tan P-H, Lee A-G (2012) Abstract P3-08-09: clinical and pathological characteristics of breast cancer in women with neurofibromatosis Type 1. Cancer Res. \n                    https:\/\/doi.org\/10.1158\/0008-5472.sabcs12-p3-08-09","journal-title":"Cancer Res"},{"issue":"16","key":"4851_CR15","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28(16):2784\u20132795. \n                    https:\/\/doi.org\/10.1200\/jco.2009.25.6529","journal-title":"J Clin Oncol"},{"issue":"31","key":"4851_CR16","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31(31):3997\u20134013. \n                    https:\/\/doi.org\/10.1200\/jco.2013.50.9984","journal-title":"J Clin Oncol"},{"key":"4851_CR17","doi-asserted-by":"publisher","unstructured":"Wong ESY, Shekar S, Met-Domestici M, Chan C, Sze M, Yap YS, Rozen SG, Tan M-H, Ang P, Ngeow J, Lee ASG (2016) Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore. 1:15003. \n                    https:\/\/doi.org\/10.1038\/npjgenmed.2015.3\n                    \n                  . \n                    https:\/\/www.nature.com\/articles\/npjgenmed20153#supplementary-information","DOI":"10.1038\/npjgenmed.2015.3"},{"issue":"12","key":"4851_CR18","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/cam4.551","volume":"4","author":"JR McPherson","year":"2015","unstructured":"McPherson JR, Ong CK, Ng CC, Rajasegaran V, Heng HL, Yu WS, Tan BK, Madhukumar P, Teo MC, Ngeow J, Thike AA, Rozen SG, Tan PH, Lee AS, Teh BT, Yap YS (2015) Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1. Cancer medicine 4(12):1871\u20131878. \n                    https:\/\/doi.org\/10.1002\/cam4.551","journal-title":"Cancer medicine"},{"issue":"4","key":"4851_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/jhg.2015.6","volume":"60","author":"A Imbard","year":"2015","unstructured":"Imbard A, Pasmant E, Sabbagh A, Luscan A, Soares M, Goussard P, Blanche H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellanne-Chantelot C, Vidaud D, Wolkenstein P, Parfait B (2015) NF1 single and multi-exons copy number variations in neurofibromatosis type 1. J Hum Genet 60(4):221\u2013224. \n                    https:\/\/doi.org\/10.1038\/jhg.2015.6","journal-title":"J Hum Genet"},{"issue":"9","key":"4851_CR20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297\u20131303. \n                    https:\/\/doi.org\/10.1101\/gr.107524.110","journal-title":"Genome Res"},{"issue":"16","key":"4851_CR21","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38(16):e164. \n                    https:\/\/doi.org\/10.1093\/nar\/gkq603","journal-title":"Nucleic Acids Res"},{"issue":"7571","key":"4851_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526(7571):68\u201374. \n                    https:\/\/doi.org\/10.1038\/nature15393","journal-title":"Nature"},{"issue":"7616","key":"4851_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O\u2019Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285\u2013291. \n                    https:\/\/doi.org\/10.1038\/nature19057","journal-title":"Nature"},{"issue":"13","key":"4851_CR24","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic acids research 31(13):3812\u20133814","journal-title":"Nucleic acids research"},{"key":"4851_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg0720s76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. \n                    https:\/\/doi.org\/10.1002\/0471142905.hg0720s76","journal-title":"Curr Protoc Hum Genet"},{"issue":"4","key":"4851_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361\u2013362. \n                    https:\/\/doi.org\/10.1038\/nmeth.2890","journal-title":"Nat Methods"},{"issue":"11","key":"4851_CR27","doi-asserted-by":"publisher","first-page":"R232","DOI":"10.1186\/gb-2007-8-11-r232","volume":"8","author":"B Reva","year":"2007","unstructured":"Reva B, Antipin Y, Sander C (2007) Determinants of protein function revealed by combinatorial entropy optimization. Genome Biol 8(11):R232. \n                    https:\/\/doi.org\/10.1186\/gb-2007-8-11-r232","journal-title":"Genome Biol"},{"issue":"3","key":"4851_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310\u2013315. \n                    https:\/\/doi.org\/10.1038\/ng.2892","journal-title":"Nat Genet"},{"issue":"7403","key":"4851_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gr\u00e4f S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Langer\u00f8d A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, B\u00f8rresen-Dale A-L, Brenton JD, Tavar\u00e9 S, Caldas C, Aparicio S (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403):346\u2013352. \n                    https:\/\/doi.org\/10.1038\/nature10983","journal-title":"Nature"},{"key":"4851_CR30","doi-asserted-by":"publisher","first-page":"11479","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Borresen-Dale AL, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C (2016) The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun 7:11479. \n                    https:\/\/doi.org\/10.1038\/ncomms11479","journal-title":"Nat Commun"},{"issue":"2","key":"4851_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1470-2045(17)30891-4","volume":"19","author":"ER Copson","year":"2018","unstructured":"Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, Eccles B, Gerty S, Durcan LT, Jones L, Evans DG, Thompson AM, Pharoah P, Easton DF, Dunning AM, Hanby A, Lakhani S, Eeles R, Gilbert FJ, Hamed H, Hodgson S, Simmonds P, Stanton L, Eccles DM (2018) Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. Lancet Oncol 19(2):169\u2013180. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(17)30891-4","journal-title":"Lancet Oncol"},{"issue":"1","key":"4851_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O\u2019Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benitez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schonbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Canadas C, Heikkinen T, Heikkila P, Aittomaki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D\u2019Andrea E, Yan M, Fox S, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC (2012) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomark Prevent 21 (1):134\u2013147. \n                    https:\/\/doi.org\/10.1158\/1055-9965.epi-11-0775","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"11","key":"4851_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/jmg.2010.078113","volume":"47","author":"JR Wilson","year":"2010","unstructured":"Wilson JR, Bateman AC, Hanson H, An Q, Evans G, Rahman N, Jones JL, Eccles DM (2010) A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J Med Genet 47(11):771\u2013774. \n                    https:\/\/doi.org\/10.1136\/jmg.2010.078113","journal-title":"J Med Genet"},{"issue":"3","key":"4851_CR34","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10549-012-1993-9","volume":"133","author":"S Masciari","year":"2012","unstructured":"Masciari S, Dillon DA, Rath M, Robson M, Weitzel JN, Balmana J, Gruber SB, Ford JM, Euhus D, Lebensohn A, Telli M, Pochebit SM, Lypas G, Garber JE (2012) Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat 133(3):1125\u20131130. \n                    https:\/\/doi.org\/10.1007\/s10549-012-1993-9","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4851_CR35","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/cncr.26377","volume":"118","author":"A Melhem-Bertrandt","year":"2012","unstructured":"Melhem-Bertrandt A, Bojadzieva J, Ready KJ, Obeid E, Liu DD, Gutierrez-Barrera AM, Litton JK, Olopade OI, Hortobagyi GN, Strong LC, Arun BK (2012) Early onset HER2-positive breast cancer is associated with germline TP53 mutations. Cancer 118(4):908\u2013913. \n                    https:\/\/doi.org\/10.1002\/cncr.26377","journal-title":"Cancer"},{"issue":"1","key":"4851_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1200\/JCO.2006.06.3024","volume":"25","author":"MK Schmidt","year":"2007","unstructured":"Schmidt MK, Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, Smit VT, Peterse JL, van Leeuwen FE, Van\u2019t Veer LJ (2007) Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol 25(1):64\u201369. \n                    https:\/\/doi.org\/10.1200\/jco.2006.06.3024","journal-title":"J Clin Oncol"},{"issue":"35","key":"4851_CR37","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1200\/JCO.2012.42.7336","volume":"30","author":"M Weischer","year":"2012","unstructured":"Weischer M, Nordestgaard BG, Pharoah P, Bolla MK, Nevanlinna H, Van\u2019t Veer LJ, Garcia-Closas M, Hopper JL, Hall P, Andrulis IL, Devilee P, Fasching PA, Anton-Culver H, Lambrechts D, Hooning M, Cox A, Giles GG, Burwinkel B, Lindblom A, Couch FJ, Mannermaa A, Grenaker Alnaes G, John EM, Dork T, Flyger H, Dunning AM, Wang Q, Muranen TA, van Hien R, Figueroa J, Southey MC, Czene K, Knight JA, Tollenaar RA, Beckmann MW, Ziogas A, Christiaens MR, Collee JM, Reed MW, Severi G, Marme F, Margolin S, Olson JE, Kosma VM, Kristensen VN, Miron A, Bogdanova N, Shah M, Blomqvist C, Broeks A, Sherman M, Phillips KA, Li J, Liu J, Glendon G, Seynaeve C, Ekici AB, Leunen K, Kriege M, Cross SS, Baglietto L, Sohn C, Wang X, Kataja V, Borresen-Dale AL, Meyer A, Easton DF, Schmidt MK, Bojesen SE (2012) CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 30(35):4308\u20134316. \n                    https:\/\/doi.org\/10.1200\/jco.2012.42.7336","journal-title":"J Clin Oncol"},{"issue":"23","key":"4851_CR38","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1200\/JCO.2016.66.5844","volume":"34","author":"MK Schmidt","year":"2016","unstructured":"Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, van den Ouweland A, Hooning M, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Arndt V, Bermisheva M, Bogdanova NV, Bolla MK, Brauch H, Brenner H, Bruning T, Burwinkel B, Chang-Claude J, Chenevix-Trench G, Couch FJ, Cox A, Cross SS, Czene K, Dunning AM, Fasching PA, Figueroa J, Fletcher O, Flyger H, Galle E, Garcia-Closas M, Giles GG, Haeberle L, Hall P, Hillemanns P, Hopper JL, Jakubowska A, John EM, Jones M, Khusnutdinova E, Knight JA, Kosma VM, Kristensen V, Lee A, Lindblom A, Lubinski J, Mannermaa A, Margolin S, Meindl A, Milne RL, Muranen TA, Newcomb PA, Offit K, Park-Simon TW, Peto J, Pharoah PD, Robson M, Rudolph A, Sawyer EJ, Schmutzler RK, Seynaeve C, Soens J, Southey MC, Spurdle AB, Surowy H, Swerdlow A, Tollenaar RA, Tomlinson I, Trentham-Dietz A, Vachon C, Wang Q, Whittemore AS, Ziogas A, van der Kolk L, Nevanlinna H, Dork T, Bojesen S, Easton DF (2016) Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. J Clin Oncol 34 (23):2750\u20132760. \n                    https:\/\/doi.org\/10.1200\/jco.2016.66.5844","journal-title":"J Clin Oncol"},{"issue":"9","key":"4851_CR39","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-08-3128","volume":"15","author":"T Heikkinen","year":"2009","unstructured":"Heikkinen T, Karkkainen H, Aaltonen K, Milne RL, Heikkila P, Aittomaki K, Blomqvist C, Nevanlinna H (2009) The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clinical Cancer Res 15(9):3214\u20133222. \n                    https:\/\/doi.org\/10.1158\/1078-0432.ccr-08-3128","journal-title":"Clinical Cancer Res"},{"issue":"6","key":"4851_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomaki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KB, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King MC, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497\u2013506. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1400382","journal-title":"N Engl J Med"},{"issue":"1","key":"4851_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/gcc.22503","volume":"57","author":"X Wang","year":"2018","unstructured":"Wang X, Teer JK, Tousignant RN, Levin AM, Boulware D, Chitale DA, Shaw BM, Chen Z, Zhang Y, Blakeley JO, Acosta MT, Messiaen LM, Korf BR, Tainsky MA (2018) Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer. Genes Chromosom Cancer 57(1):19\u201327. \n                    https:\/\/doi.org\/10.1002\/gcc.22503","journal-title":"Genes Chromosom Cancer"},{"issue":"2","key":"4851_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccr.2005.07.004","volume":"8","author":"Y Zhu","year":"2005","unstructured":"Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF (2005) Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8(2):119\u2013130. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2005.07.004","journal-title":"Cancer Cell"},{"issue":"17","key":"4851_CR43","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1158\/1078-0432.CCR-13-0398","volume":"19","author":"VJ Mar","year":"2013","unstructured":"Mar VJ, Wong SQ, Li J, Scolyer RA, McLean C, Papenfuss AT, Tothill RW, Kakavand H, Mann GJ, Thompson JF, Behren A, Cebon JS, Wolfe R, Kelly JW, Dobrovic A, McArthur GA (2013) BRAF\/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage. Clin Cancer Res 19(17):4589\u20134598. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0398","journal-title":"Clin Cancer Res"},{"issue":"9","key":"4851_CR44","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ng.2359","volume":"44","author":"M Krauthammer","year":"2012","unstructured":"Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Hayward NK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 44(9):1006\u20131014. \n                    https:\/\/doi.org\/10.1038\/ng.2359","journal-title":"Nat Genet"},{"issue":"12","key":"4851_CR45","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1593\/neo.08784","volume":"10","author":"N Sangha","year":"2008","unstructured":"Sangha N, Wu R, Kuick R, Powers S, Mu D, Fiander D, Yuen K, Katabuchi H, Tashiro H, Fearon ER, Cho KR (2008) Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. Neoplasia 10(12):1362\u20131372","journal-title":"Neoplasia"},{"issue":"6","key":"4851_CR46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrc3929","volume":"15","author":"RC Rao","year":"2015","unstructured":"Rao RC, Dou Y (2015) Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer 15(6):334\u2013346. \n                    https:\/\/doi.org\/10.1038\/nrc3929","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4851_CR47","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ccr.2014.03.016","volume":"25","author":"C Chen","year":"2014","unstructured":"Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, Lowe SW (2014) MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell 25(5):652\u2013665. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2014.03.016","journal-title":"Cancer Cell"},{"issue":"4","key":"4851_CR48","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.18632\/oncotarget.2967","volume":"6","author":"L Liu","year":"2015","unstructured":"Liu L, Kimball S, Liu H, Holowatyj A, Yang ZQ (2015) Genetic alterations of histone lysine methyltransferases and their significance in breast cancer. Oncotarget 6(4):2466\u20132482. \n                    https:\/\/doi.org\/10.18632\/oncotarget.2967","journal-title":"Oncotarget"},{"issue":"2","key":"4851_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12253-010-9316-0","volume":"17","author":"XX Wang","year":"2011","unstructured":"Wang XX, Fu L, Li X, Wu X, Zhu Z, Fu L, Dong JT (2011) Somatic mutations of the mixed-lineage leukemia 3 (MLL3) gene in primary breast cancers. Pathol Oncol Res 17(2):429\u2013433. \n                    https:\/\/doi.org\/10.1007\/s12253-010-9316-0","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"4851_CR50","doi-asserted-by":"publisher","first-page":"e135-e142","DOI":"10.1016\/j.clbc.2016.11.005","volume":"17","author":"K Sato","year":"2017","unstructured":"Sato K, Akimoto K (2017) Expression levels of KMT2C and SLC20A1 identified by information-theoretical analysis are powerful prognostic biomarkers in estrogen receptor-positive breast cancer. Clin Breast Cancer 17(3):e135-e142. \n                    https:\/\/doi.org\/10.1016\/j.clbc.2016.11.005","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"4851_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","volume":"32","author":"LR Yates","year":"2017","unstructured":"Yates LR, Knappskog S, Wedge D, Farmery JHR, Gonzalez S, Martincorena I, Alexandrov LB, Van Loo P, Haugland HK, Lilleng PK, Gundem G, Gerstung M, Pappaemmanuil E, Gazinska P, Bhosle SG, Jones D, Raine K, Mudie L, Latimer C, Sawyer E, Desmedt C, Sotiriou C, Stratton MR, Sieuwerts AM, Lynch AG, Martens JW, Richardson AL, Tutt A, Lonning PE, Campbell PJ (2017) Genomic evolution of breast cancer metastasis and relapse. Cancer Cell 32(2):169\u2013184.e167. \n                    https:\/\/doi.org\/10.1016\/j.ccell.2017.07.005","journal-title":"Cancer Cell"},{"issue":"11","key":"4851_CR52","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/humu.22392","volume":"34","author":"A Sabbagh","year":"2013","unstructured":"Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanch\u00e9 H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellann\u00e9-Chantelot C, Vidaud D, Parfait B, Wolkenstein P (2013) NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat 34(11):1510\u20131518. \n                    https:\/\/doi.org\/10.1002\/humu.22392","journal-title":"Hum Mutat"},{"issue":"2","key":"4851_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jmoldx.2010.09.002","volume":"13","author":"MC Valero","year":"2011","unstructured":"Valero MC, Mart\u00edn Y, Hern\u00e1ndez-Imaz E, Marina Hern\u00e1ndez A, Mele\u00e1n G, Valero AM, Javier Rodr\u00edguez-\u00c1lvarez F, Teller\u00eda D, Hern\u00e1ndez-Chico C (2011) A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn 13(2):113\u2013122. \n                    https:\/\/doi.org\/10.1016\/j.jmoldx.2010.09.002","journal-title":"J Mol Diagn"},{"issue":"3","key":"4851_CR54","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1158\/2159-8290.CD-12-0313","volume":"3","author":"O Maertens","year":"2013","unstructured":"Maertens O, Johnson B, Hollstein P, Frederick DT, Cooper ZA, Messiaen L, Bronson RT, McMahon M, Granter S, Flaherty K, Wargo JA, Marais R, Cichowski K (2013) Elucidating distinct roles for NF1 in melanomagenesis. Cancer Discov 3(3):338\u2013349. \n                    https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0313","journal-title":"Cancer Discov"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4851-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T19:25:14Z","timestamp":1561058714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4851-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4851"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4851-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]},"assertion":[{"value":"4 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients for this study provided written informed consent, except for deceased patients (waiver of consent for deceased patients granted by institutional review board).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}